By - Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
- Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial CNBC
- Moderna Shares Skyrocket 85% Toward Best Day Ever—Here’s Why Forbes
- Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STAT
- Cancer treatment could face landmark moment with promising vaccine washingtonpost.com
Originally published on news.google.com — View original